Association of Relative Pericoronary Adipose Tissue Attenuation with Coronary Artery Calcification Severity.
KZ, L., RM, P., RA, L., CR, M., A, M., BÁ, B., AM, L., FS, S., Z, P., & M, P. (2026). Association of Relative Pericoronary Adipose Tissue Attenuation with Coronary Artery Calcification Severity.. Medicina (Kaunas, Lithuania). https://doi.org/10.3390/medicina62050990
KZ L, RM P, RA L, CR M, A M, BÁ B, et al. Association of Relative Pericoronary Adipose Tissue Attenuation with Coronary Artery Calcification Severity.. Medicina (Kaunas, Lithuania). 2026; doi: 10.3390/medicina62050990
KZ L, RM P, RA L, et al. Association of Relative Pericoronary Adipose Tissue Attenuation with Coronary Artery Calcification Severity.[J]. Medicina (Kaunas, Lithuania). 2026. DOI: 10.3390/medicina62050990.
@article{kz2026,
author = {Lőrincz KZ and Pop RM and Licu RA and Mariean CR and Manea A and Baróti BÁ and Licu AM and Suaibu FS and Pap Z and Pop M},
title = {Association of Relative Pericoronary Adipose Tissue Attenuation with Coronary Artery Calcification Severity.},
journal = {Medicina (Kaunas, Lithuania)},
year = {2026},
doi = {10.3390/medicina62050990},
note = {PMID: 42195243},
}
TY - JOUR AU - Lőrincz KZ AU - Pop RM AU - Licu RA AU - Mariean CR AU - Manea A AU - Baróti BÁ AU - Licu AM AU - Suaibu FS AU - Pap Z AU - Pop M TI - Association of Relative Pericoronary Adipose Tissue Attenuation with Coronary Artery Calcification Severity. T2 - Medicina (Kaunas, Lithuania) PY - 2026 DO - 10.3390/medicina62050990 AN - PMID:42195243 ER -
Background and Objectives: Pericoronary adipose tissue (PCAT) attenuation measured on coronary CT angiography is a promising imaging biomarker of coronary inflammation; however, absolute values may be influenced by technical and inter-individual variability, and a standardized methodology for measurement has not been established. Our study aimed to evaluate the association between PCAT attenuation and CAC burden while comparing absolute attenuation values with normalized values to minimize these sources of variability. Materials and Methods: Two hundred patients undergoing cardiac CT were included and stratified into four CAC categories (0, 1-99, 100-299, ≥300). PCAT attenuation was measured at multiple locations on two main levels: aortic root level and four-chamber view level. Relative PCAT attenuation was calculated by subtracting subcutaneous fat attenuation from raw PCAT values. Group comparisons were performed using ANOVA or Kruskal-Wallis tests, and multivariable linear regression models were adjusted for age, sex, and body mass index. Results: In univariate analysis, relative PCAT attenuation differed significantly across CAC categories at the aortic-level right coronary artery (RCA) site (p = 0.007). In multivariable analysis, higher CAC categories were associated with increased relative PCAT attenuation at the aortic RCA (β = 8.56, p = 0.015 for CAC 100-299; β = 10.68, p = 0.005 for CAC ≥300), while associations at the left main coronary artery (LMCA) showed significance in low and moderate CAC categories (β = 6.91, p = 0.047 for CAC 1-99 and β = 8.57, p = 0.016 for CAC 100-299). No significant associations were observed between CAC and raw PCAT attenuation at the aortic level, while isolated and inconsistent findings were observed in other territories. Conclusions: Relative PCAT attenuation is independently associated with CAC severity and normalized values may reduce technical and biological variability, potentially enhancing the sensitivity and robustness of this CT-based biomarker.